While Tectonic Therapeutic Inc has underperformed by -4.22%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TECX fell by -67.55%, with highs and lows ranging from $61.07 to $13.70, whereas the simple moving average fell by -44.89% in the last 200 days.
On September 03, 2025, Oppenheimer started tracking Tectonic Therapeutic Inc (NASDAQ: TECX) recommending Outperform. A report published by Truist on July 21, 2025, Initiated its previous ‘Buy’ rating for TECX. Raymond James also rated TECX shares as ‘Outperform’, setting a target price of $76 on the company’s shares in an initiating report dated June 11, 2025. Mizuho Initiated an Outperform rating on April 21, 2025, and assigned a price target of $51. Raymond James initiated its ‘Outperform’ rating for TECX, as published in its report on November 20, 2024. Wells Fargo’s report from August 22, 2024 suggests a price prediction of $55 for TECX shares, giving the stock a ‘Overweight’ rating. Piper Sandler also rated the stock as ‘Overweight’.
Analysis of Tectonic Therapeutic Inc (TECX)
In order to gain a clear picture of Tectonic Therapeutic Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -29.32% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 25.60, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 336.71K can be a very valuable indicator of volatility for TECX stock. On a monthly basis, the volatility of the stock is set at 8.58%, whereas on a weekly basis, it is put at 8.80%, with a loss of -15.46% over the past seven days. Furthermore, long-term investors anticipate a median target price of $79.75, showing growth from the present price of $14.98, which can serve as yet another indication of whether TECX is worth investing in or should be passed over.
How Do You Analyze Tectonic Therapeutic Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 43.42%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 61.20% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
